The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of cadonilimab (CD) in combination with disitamab vedotin (RC48) or nab-paclitaxel (NP) in the treatment of recurrent or metastatic cervical cancer (r/mCC): A prospective, double-cohort, multicenter, open-label, phase II clinical study.
 
Min Zheng
No Relationships to Disclose
 
Haifeng Gu
No Relationships to Disclose
 
Jian Zhou
No Relationships to Disclose
 
Jianwei Wang
No Relationships to Disclose
 
Lili Liu
No Relationships to Disclose
 
Yun Zhou
No Relationships to Disclose
 
Baoyue Pan
No Relationships to Disclose
 
Qingna Chen
No Relationships to Disclose
 
Huijuan He
No Relationships to Disclose
 
Weijun Ye
No Relationships to Disclose
 
Yan Ding
No Relationships to Disclose
 
Li Zhou
No Relationships to Disclose
 
Li Sun
No Relationships to Disclose
 
Mingyi Li
No Relationships to Disclose
 
Xinping Cao
No Relationships to Disclose
 
Jin-Xin Bei
No Relationships to Disclose